Search by Drug Name or NDC
NDC 69097-0664-68 ICATIBANT 30 mg/3mL Details
ICATIBANT 30 mg/3mL
ICATIBANT is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is ICATIBANT ACETATE.
Product Information
| NDC | 69097-0664 |
|---|---|
| Product ID | 69097-664_3c1d55c7-6696-40da-86f4-b6e00e8bc6fe |
| Associated GPIs | 85820040102020 |
| GCN Sequence Number | 064564 |
| GCN Sequence Number Description | icatibant acetate SYRINGE 30 MG/3 ML SUBCUT |
| HIC3 | A7M |
| HIC3 Description | BRADYKININ B2 RECEPTOR ANTAGONISTS |
| GCN | 14778 |
| HICL Sequence Number | 035962 |
| HICL Sequence Number Description | ICATIBANT ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | ICATIBANT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ICATIBANT |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/3mL |
| Substance Name | ICATIBANT ACETATE |
| Labeler Name | Cipla USA Inc. |
| Pharmaceutical Class | Bradykinin B2 Receptor Antagonist [EPC], Bradykinin B2 Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212446 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0664-68 (69097066468)
| NDC Package Code | 69097-664-68 |
|---|---|
| Billing NDC | 69097066468 |
| Package | 3 SYRINGE, GLASS in 1 CARTON (69097-664-68) / 3 mL in 1 SYRINGE, GLASS |
| Marketing Start Date | 2020-07-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |